Program helps cancer survivors return to work with confidence Updated on: July 13,2025 Program helps cancer survivors return to work with confidence Updated on:July 13,2025
AI tool analyzes blood DNA fragments for faster, affordable cancer monitoring Updated on: July 13,2025 AI tool analyzes blood DNA fragments for faster, affordable cancer monitoring Updated on:July 13,2025
Blocking CD200R1 protein offers new strategy for treatment-resistant blood cancers Updated on: July 13,2025 Blocking CD200R1 protein offers new strategy for treatment-resistant blood cancers Updated on:July 13,2025
Blood-based screening has acceptable accuracy for colorectal cancer detection Updated on: July 12,2025 Blood-based screening has acceptable accuracy for colorectal cancer detection Updated on:July 12,2025
Experimental model for myelodysplastic syndromes uncovers genetic alterations to improve characterization Updated on: July 12,2025 Experimental model for myelodysplastic syndromes uncovers genetic alterations to improve characterization Updated on:July 12,2025
Liver cancer patients see longer survival with dual immunotherapy approach Updated on: July 12,2025 Liver cancer patients see longer survival with dual immunotherapy approach Updated on:July 12,2025
Switching off key gene makes NK cells more sensitive to cancer-fighting signals Updated on: July 12,2025 Switching off key gene makes NK cells more sensitive to cancer-fighting signals Updated on:July 12,2025
Breast cancer patients with BRCA mutations and textured implants found to have increased risk of rare lymphoma Updated on: July 12,2025 Breast cancer patients with BRCA mutations and textured implants found to have increased risk of rare lymphoma Updated on:July 12,2025
Modified CAR-T cells target widespread protein found in multiple types of cancer Updated on: July 12,2025 Modified CAR-T cells target widespread protein found in multiple types of cancer Updated on:July 12,2025
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression Updated on: July 12,2025 FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression Updated on:July 12,2025